BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 11408503)

  • 1. Bony morbidity in children treated for acute lymphoblastic leukemia.
    Strauss AJ; Su JT; Dalton VM; Gelber RD; Sallan SE; Silverman LB
    J Clin Oncol; 2001 Jun; 19(12):3066-72. PubMed ID: 11408503
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Osteonecrosis as a complication of treating acute lymphoblastic leukemia in children: a report from the Children's Cancer Group.
    Mattano LA; Sather HN; Trigg ME; Nachman JB
    J Clin Oncol; 2000 Sep; 18(18):3262-72. PubMed ID: 10986059
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Postinduction dexamethasone and individualized dosing of Escherichia Coli L-asparaginase each improve outcome of children and adolescents with newly diagnosed acute lymphoblastic leukemia: results from a randomized study--Dana-Farber Cancer Institute ALL Consortium Protocol 00-01.
    Vrooman LM; Stevenson KE; Supko JG; O'Brien J; Dahlberg SE; Asselin BL; Athale UH; Clavell LA; Kelly KM; Kutok JL; Laverdière C; Lipshultz SE; Michon B; Schorin M; Relling MV; Cohen HJ; Neuberg DS; Sallan SE; Silverman LB
    J Clin Oncol; 2013 Mar; 31(9):1202-10. PubMed ID: 23358966
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Skeletal morbidity in children receiving chemotherapy for acute lymphoblastic leukaemia.
    Elmantaser M; Stewart G; Young D; Duncan R; Gibson B; Ahmed SF
    Arch Dis Child; 2010 Oct; 95(10):805-9. PubMed ID: 20576660
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Osteonecrosis: An emerging complication of intensive chemotherapy for childhood acute lymphoblastic leukemia.
    Aricò M; Boccalatte MF; Silvestri D; Barisone E; Messina C; Chiesa R; Santoro N; Tamaro P; Lippi A; Gallisai D; Basso G; De Rossi G;
    Haematologica; 2003 Jul; 88(7):747-53. PubMed ID: 12857552
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High body mass index increases the risk for osteonecrosis in children with acute lymphoblastic leukemia.
    Niinimäki RA; Harila-Saari AH; Jartti AE; Seuri RM; Riikonen PV; Pääkkö EL; Möttönen MI; Lanning M
    J Clin Oncol; 2007 Apr; 25(12):1498-504. PubMed ID: 17442991
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prospective study on incidence, risk factors, and long-term outcome of osteonecrosis in pediatric acute lymphoblastic leukemia.
    te Winkel ML; Pieters R; Hop WC; de Groot-Kruseman HA; Lequin MH; van der Sluis IM; Bökkerink JP; Leeuw JA; Bruin MC; Egeler RM; Veerman AJ; van den Heuvel-Eibrink MM
    J Clin Oncol; 2011 Nov; 29(31):4143-50. PubMed ID: 21947829
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of alternate-week versus continuous dexamethasone scheduling on the risk of osteonecrosis in paediatric patients with acute lymphoblastic leukaemia: results from the CCG-1961 randomised cohort trial.
    Mattano LA; Devidas M; Nachman JB; Sather HN; Hunger SP; Steinherz PG; Gaynon PS; Seibel NL;
    Lancet Oncol; 2012 Sep; 13(9):906-15. PubMed ID: 22901620
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Obesity after successful treatment of acute lymphoblastic leukemia in childhood.
    Van Dongen-Melman JE; Hokken-Koelega AC; Hählen K; De Groot A; Tromp CG; Egeler RM
    Pediatr Res; 1995 Jul; 38(1):86-90. PubMed ID: 7478803
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Substituting dexamethasone for prednisone complicates remission induction in children with acute lymphoblastic leukemia.
    Hurwitz CA; Silverman LB; Schorin MA; Clavell LA; Dalton VK; Glick KM; Gelber RD; Sallan SE
    Cancer; 2000 Apr; 88(8):1964-9. PubMed ID: 10760775
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predictors of bony morbidity in children with acute lymphoblastic leukemia.
    Rayar MS; Nayiager T; Webber CE; Barr RD; Athale UH
    Pediatr Blood Cancer; 2012 Jul; 59(1):77-82. PubMed ID: 22190454
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Osteonecrosis in children with acute lymphoblastic leukemia: A report from Children's Cancer Hospital Egypt (CCHE).
    Ali N; Gohar S; Zaky I; Elghoneimy A; Youssef S; Sameer G; Yassin D; Salem S; Magdi H; Sidhom I
    Pediatr Blood Cancer; 2019 Jan; 66(1):e27440. PubMed ID: 30183135
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Osteonecrosis as a complication of treating acute lymphoblastic leukemia in children: a report from the Children's Cancer Group.
    Levien MG
    Clin Pediatr (Phila); 2002; 41(1):63-4. PubMed ID: 11866371
    [No Abstract]   [Full Text] [Related]  

  • 14. Osteonecrosis: a treatment related toxicity in childhood acute lymphoblastic leukemia (ALL)--experiences from trial ALL-BFM 95.
    Bürger B; Beier R; Zimmermann M; Beck JD; Reiter A; Schrappe M
    Pediatr Blood Cancer; 2005 Mar; 44(3):220-5. PubMed ID: 15514916
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comparison of neurocognitive functioning in children previously randomized to dexamethasone or prednisone in the treatment of childhood acute lymphoblastic leukemia.
    Kadan-Lottick NS; Brouwers P; Breiger D; Kaleita T; Dziura J; Liu H; Chen L; Nicoletti M; Stork L; Bostrom B; Neglia JP
    Blood; 2009 Aug; 114(9):1746-52. PubMed ID: 19546477
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bloodstream infections exacerbate incidence and severity of symptomatic glucocorticoid-induced osteonecrosis.
    Finch ER; Janke LJ; Smith CA; Karol SE; Pei D; Cheng C; Kaste SC; Inaba H; Pui CH; Wolf J; Relling MV
    Pediatr Blood Cancer; 2019 Jun; 66(6):e27669. PubMed ID: 30758124
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Osteonecrosis during the treatment of childhood acute lymphoblastic leukemia: a prospective MRI study.
    Ojala AE; Pääkkö E; Lanning FP; Lanning M
    Med Pediatr Oncol; 1999 Jan; 32(1):11-7. PubMed ID: 9917747
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dexamethasone-associated toxicity during induction chemotherapy for childhood acute lymphoblastic leukemia is augmented by concurrent use of daunomycin.
    Belgaumi AF; Al-Bakrah M; Al-Mahr M; Al-Jefri A; Al-Musa A; Saleh M; Salim MF; Osman M; Osman L; El-Solh H
    Cancer; 2003 Jun; 97(11):2898-903. PubMed ID: 12767105
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Steroid withdrawal syndrome during steroid tapering in childhood acute lymphoblastic leukemia: a controlled study comparing prednisone versus dexamethasone in induction phase.
    Saracco P; Bertorello N; Farinasso L; Einaudi S; Barisone E; Altare F; Corrias A; Pastore G
    J Pediatr Hematol Oncol; 2005 Mar; 27(3):141-4. PubMed ID: 15750445
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Osteonecrosis in paediatric patients with acute lymphoblastic leukaemia treated on Co-ALL-07-03 trial: a single centre analysis.
    Kuhlen M; Moldovan A; Krull K; Meisel R; Borkhardt A
    Klin Padiatr; 2014 May; 226(3):154-60. PubMed ID: 24710762
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.